Steele Capital Management
ABBV icon

Steele Capital Management’s AbbVie ABBV Stock Holding History

Steele Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.39M Buy
12,948
+248
+2% +$63.6K 0.13% 55
2026
Q2 		$3.2M Sell
12,700
-99
-0.8% -$21.3K 0.12% 57
2026
Q1 		$2.78M Sell
12,799
-382
-3% -$84.7K 0.12% 60
2025
Q4 		$3.01M Buy
13,181
+1
+0% +$228 0.13% 55
2025
Q3 		$3.05M Buy
13,180
+300
+2% +$61.1K 0.14% 55
2025
Q2 		$2.39M Sell
12,880
-885
-6% -$164K 0.11% 55
2025
Q1 		$2.88M Buy
13,765
+127
+0.9% +$24.7K 0.15% 51
2024
Q4 		$2.42M Buy
13,638
+24
+0.2% +$4.41K 0.13% 50
2024
Q3 		$2.69M Buy
13,614
+14
+0.1% +$2.61K 0.14% 48
2024
Q2 		$2.33M Sell
13,600
-21
-0.2% -$3.48K 0.13% 49
2024
Q1 		$2.48M Buy
13,621
+360
+3% +$62K 0.14% 49
2023
Q4 		$2.06M Buy
+13,261
New +$1.93M 0.13% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Steele Capital Management's ABBV Position: Q3 2026 in Review

Steele Capital Management increased its AbbVie (ABBV) stake by 2% in Q3 2026, buying an estimated $63.6K and bringing the position to 12,948 shares worth $3.39M. The position accounts for 0.13% of the portfolio, ranked #55.

Steele Capital Management first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Steele Capital Management held 12,948 shares of AbbVie worth $3.39M as of Q3 2026.
  • Steele Capital Management bought 248 AbbVie shares in Q3 2026, an estimated $63.6K.
  • AbbVie made up 0.13% of Steele Capital Management's portfolio in Q3 2026, its #55 holding.
  • Steele Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Steele Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.